Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat ...
Biohaven (BHVN) downgraded after FDA setback for VYGLXIA. Learn key risks, pipeline shifts, and what investors should watch ...
A higher-titer ANA raises the suspicion that something more systemic may be going on,’ said Amanda Mixon, PA-C.
News-Medical.Net on MSN
Rockefeller scientists engineer next-generation antibody to replace IVIG therapy
Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat ...
Toxoplasma gondii poses serious risks during pregnancy and to those with weakened immune systems, and Clinicians must ...
SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“the Company” or ...
Mycoplasma pneumoniae infections have risen significantly post-COVID-19, presenting with both respiratory and increasing ...
Scientists have found that they may be able to use the retina's blood vessels to help predict a person's heart disease risk ...
Researchers at McMaster University have discovered that the eyes may offer a powerful, non-invasive way to assess heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback